Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Candida Albicans Infection”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Not applicableUnknownNCT03462862
What this trial is testing

Evaluation of Candida Albicans Growth on BreFlex Versus PEEK Denture Base in Maxillary Bounded Partial Denture

Who this might be right for
Candida Albicans Infection
Cairo University 18
Not applicableStudy completedNCT00721487
What this trial is testing

Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections

Who this might be right for
Fungal Infection by Site
CPL Associates 28
Post-approval studies (Phase 4)Study completedNCT00001542
What this trial is testing

Fluconazole Prophylaxis of Thrush in AIDS

Who this might be right for
Acquired Immunodeficiency SyndromeCandidiasisOral Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06450990
What this trial is testing

Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection

Who this might be right for
Bacterial VaginosisVulvovaginal Candidiasis
NEXBIOME THERAPEUTICS 165
Not applicableNot Yet RecruitingNCT07245563
What this trial is testing

Biofilm Formation and Antifungal Resistance in Candida Species

Who this might be right for
Candida Infection
Assiut University 300
Large-scale testing (Phase 3)Looking for participantsNCT03580733
What this trial is testing

Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis

Who this might be right for
ICU Yeast Intra-abdominal Infection
Centre Hospitalier Universitaire, Amiens 448
Testing effectiveness (Phase 2)Study completedNCT01891331
What this trial is testing

Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Candidiasis, Vulvovaginal
Viamet 55
Not applicableStudy completedNCT06146504
What this trial is testing

Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement

Who this might be right for
Candida SystemicCandida Albicans InfectionCandida Infection
CanXida 60
Testing effectiveness (Phase 2)Ended earlyNCT02996448
What this trial is testing

Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome

Who this might be right for
Autosomal-dominant Hyper-IgE Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 3
Testing effectiveness (Phase 2)Study completedNCT02971007
What this trial is testing

Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)

Who this might be right for
VulvovaginitisYeast InfectionYeast Infection Vaginal+1 more
Matinas BioPharma Nanotechnologies, Inc. 137
Testing effectiveness (Phase 2)Study completedNCT02733432
What this trial is testing

RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Who this might be right for
Candidiasis, VulvovaginalMycosesYeast Infection+2 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 126
Testing effectiveness (Phase 2)Study completedNCT03372395
What this trial is testing

Probiotic Implementation as Help in Solving Vaginal Infections

Who this might be right for
Vaginal InfectionASC-US
University of Roma La Sapienza 117
Early research (Phase 1)Study completedNCT00000958
What this trial is testing

A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Not applicableAvailableNCT06433128
What this trial is testing

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica
Large-scale testing (Phase 3)Study completedNCT03562156
What this trial is testing

Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 438
Not applicableStudy completedNCT04219605
What this trial is testing

Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions

Who this might be right for
Bacterial VaginosisCandida Albicans VulvovaginitisCandida Vulvovaginitis+3 more
Meir Medical Center 226
Not applicableUnknownNCT04215458
What this trial is testing

Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases

Who this might be right for
Fungal InfectionInflammatory Skin DiseaseYeast Infection Skin
Zealand University Hospital 700
Large-scale testing (Phase 3)Study completedNCT03987620
What this trial is testing

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

Who this might be right for
Candida Vulvovaginitis
Scynexis, Inc. 455
Post-approval studies (Phase 4)Study completedNCT02021123
What this trial is testing

Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)

Who this might be right for
Obesity Morbid
Radboud University Medical Center 8
Large-scale testing (Phase 3)Study completedNCT04029116
What this trial is testing

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Scynexis, Inc. 440
Load More Results